Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk

American Journal of Public Health

Volumn 99, Issue 12, 2009, Pages 2184-2187

  Hsu, Angela ^a   Card, Andrea ^a   Lin, Susan Xiaoqin ^a   Mota, Sean ^a   Carrasquillo, Olveen ^a   Moran, Andrew ^a  

^a Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; NATIONAL HEALTH AND NUTRITION SURVEY; POSTMENOPAUSE;

AGED; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; UNITED STATES;

EID: 72249117178     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2009.159889     Document Type: Article

References (14)

1. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1): 47-53.
2. Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. JAMA. 2004; 292(16):1983-1988. (Pubitemid 39411207)
3. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14): 1701-1712. (Pubitemid 38489892)
4. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group [see comment]. JAMA. 1998;280(7):605-613.
5. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial [see comment]. JAMA. 2002;288(3):321-333.
6. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 2003;289(20):2673-2684. (Pubitemid 37430138)
7. Haas JS, Geller B, Miglioretti DL, et al. Changes in newspaper coverage about hormone therapy with the release of new medical evidence. J Gen Intern Med. 2006;21(4):304-309.
8. Haas JS, Miglioretti DL, Geller B, et al. Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use. J Gen Intern Med. 2007;22(1):68-73. (Pubitemid 47308798)
9. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results [see comment]. Ann Intern Med. 2004;140(3):184-188. (Pubitemid 38155649)
10. National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; 2003-2004.
11. National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; 2001-2002.
12. National Health and Nutrition Examination Survey Questionnaire (or Examination Protocol, or Laboratory Protocol). Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; 1999-2000.
13. National Healthcare Disparities Report. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
14. Smedley BSA, Nelson A. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2003.